APA (7th ed.) Citation

V, R., C, A., N, A., YS, C., H, E., M, F., . . . MP, H. (2026). Managing remnant cholesterol: Role of fenofibrate-statin therapy in reducing triglyceride-rich lipoproteins. Frontiers in cardiovascular medicine, 13, 1837004. https://doi.org/10.3389/fcvm.2026.1837004

Chicago Style (17th ed.) Citation

V, Raja, et al. "Managing Remnant Cholesterol: Role of Fenofibrate-statin Therapy in Reducing Triglyceride-rich Lipoproteins." Frontiers in Cardiovascular Medicine 13 (2026): 1837004. https://doi.org/10.3389/fcvm.2026.1837004.

MLA (9th ed.) Citation

V, Raja, et al. "Managing Remnant Cholesterol: Role of Fenofibrate-statin Therapy in Reducing Triglyceride-rich Lipoproteins." Frontiers in Cardiovascular Medicine, vol. 13, 2026, p. 1837004, https://doi.org/10.3389/fcvm.2026.1837004.